Biotech entrepreneurs across Asia are navigating funding gaps, weak innovation ecosystems, and unpredictable regulatory systems. For many, these challenges make it difficult to scale science-led businesses and deliver affordable healthcare solutions.

In this episode, host Gautam Kumra, Chairman of McKinsey Asia, sits down with Kiran Mazumdar-Shaw, Founder & Chairperson, Biocon Group. They discuss how she overcame a lack of funding, limited infrastructure, and regulatory hurdles to build one of Asia’s first and most successful biotech companies — pioneering affordable biosimilars, shaping biotech policy in India, and scaling purpose-driven innovation from the ground up.

The episode also features McKinsey partner Cheryl SH Lim, and Director of Learning, CEO Institute, Jennifer Chiang.

See www.mckinsey.com/privacy-policy for privacy information

Indonesia has set an ambition to become a high-income economy by 2045. Is this possible? Two McKinsey experts discuss how it could be and what actions would need to be taken to achieve it.

See www.mckinsey.com/privacy-policy for privacy information

Business leaders are facing an unprecedented mix of economic shifts, AI breakthroughs, and trade realignments. Traditional strategies no longer guarantee stability, and companies must rethink their approach.

In this episode, host Clay Chandler, Executive Editor for Asia at Fortune, speaks with Gautam Kumra, Chairman of McKinsey Asia, and Joe Ngai, Chairman of McKinsey’s Greater China offices. They share insights from the World Economic Forum Annual Meeting in Davos, discuss Asia’s evolving role in global markets, and explore what it takes for businesses to stay competitive.

See www.mckinsey.com/privacy-policy for privacy information